Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 8:39 AM ET

Healthcare Equipment and Supplies

Company Overview of CooperVision, Inc.

Company Overview

CooperVision, Inc. designs and manufactures eye contact lenses and related products. It offers monthly, two-week, and daily disposable silicone hydrogel contact lenses for patients with astigmatism, nearsightedness, farsightedness, presbyopia, and more. The company also offers spherical, toric, and multifocal products. It sells its products to customers in the United States and internationally. The company was founded in 1979 and is based in Fairport, New York with regional locations in the Americas, Europe, the Asia Pacific, Africa, and Central Eurasia. CooperVision, Inc. operates as a subsidiary of The Cooper Companies Inc.

370 Woodcliff Drive

Suite 200

Fairport, NY 14450

United States

Founded in 1979

Phone:

716-385-6810

Fax:

716-889-5688

Key Executives for CooperVision, Inc.

President and Chief Operating Officer
Age: 51
Chief Financial Officer and Vice President
Senior Vice President of Global Professional & Clinical Affairs
Global Managing Director of International Accounts
Vice President of Global Marketing
Compensation as of Fiscal Year 2015.

CooperVision, Inc. Key Developments

EP Global Communications, Inc. Reaches Settlement Agreement with CooperVision, Inc

EP Global Communications, Inc. executed a Settlement Agreement with CooperVision Inc. on December 31, 2015. In 2014, the two Companies worked together to jointly develop advanced contact lens technology concepts. On December 31, 2015 the parties executed a Settlement Agreement setting the parties' respective rights in the jointly filed patent applications and allowing each party to separately and independently pursue these contact lens concepts. The settlement also addresses the ongoing prosecution of several related joint patent applications. CooperVision is to pay EPGL an undisclosed cash component and will retain certain rights to use the technologies disclosed in the jointly filed patent applications to develop and commercialize contact lenses and relinquish all rights to other patent applications filed by EPGL. In exchange, EPGL gains sole ownership and control of the jointly filed patent applications and unlimited worldwide marketing right to license the technologies disclosed in the jointly filed patent applications to all other manufacturers and partners worldwide. EPGL will earn 100% of all future revenues from such potential deals going forward.

CooperVision Announces Earnings Results for the Fourth Quarter of 2015; Provides Earnings Guidance for the First Quarter and Full Year of 2016

CooperVision announced earnings results for the fourth quarter of 2015. For the quarter, the company reported revenues of $373 million, down 3% year-over-year but up 5% in constant currency and up 7% in constant currency, excluding solutions. Non-GAAP operating income and margin were $100.2 million and 26.8% of revenue versus $98 million and 25.4% of revenue in the prior year. For the fiscal 2016, the company expects revenue range is $1.509 billion to $1.539 billion or 5% to 7% constant-currency growth. For the first quarter of fiscal 2016, the company expects revenues in the $356 million to $366 million range or 3% to 5% constant-currency growth.

CooperVision to Invest USD 40 Million into Hungary Unit

CooperVision is to invest USD 40 million over the next three years at its unit in Gyal, near Budapest. The investment will create 400 jobs.

Similar Private Companies By Industry

Company Name Region
TissueGen, Inc. United States
Eyenovia, Inc. United States
Respironics Georgia, Inc. United States
Thinoptics, Inc. United States
Impres Medical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CooperVision, Inc., please visit www.coopervision.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.